Efficient and effective scale-up of production for viral vectors and allogeneic cell therapies and scale-out of production for autologous cell therapies are absolutely key to the development of commercially viable products. This webinar provides an opportunity to hear from leading experts:
They share their insights and experiences in addressing the myriad challenges of effective scalability of cell and gene therapies, including:
*By registering to view this Webinar you are also signing up as a member of Cell & Gene Therapy Insights and agree to be contacted by our sponsors. We will email you a username and password so you can read all our open access content.